Expert consensus pushes to redefine, manage rare liver disease

A multinational, multidisciplinary group of experts has created a consensus document to guide diagnosis, staging and management of adults with alpha-1 antitrypsin deficiency-associated liver disease, as well as advance research efforts.
Paul Kwo, MD, FAASLD, director of hepatology and professor of medicine at Stanford University, was part of the panel that convened under the auspices of AGA in collaboration with American Association for the Study of Liver Diseases, European Association for the Study of the Liver and Alpha-1 Foundation. The document was published in Gastroenterology.
“Although
